Oldham W
Am J Respir Crit Care Med. 2024; 210(3):256-257.
PMID: 38780073
PMC: 11348971.
DOI: 10.1164/rccm.202404-0695ED.
Hu P, Du Y, Xu Y, Ye P, Xia J
Front Cardiovasc Med. 2024; 11:1384294.
PMID: 38745757
PMC: 11091331.
DOI: 10.3389/fcvm.2024.1384294.
Mohammad M, Hartmann J, Carlsen J, Greve A, Berg R, Mortensen J
Exp Physiol. 2024; 109(7):1040-1050.
PMID: 38725160
PMC: 11215485.
DOI: 10.1113/EP091688.
Tuder R, Gandjeva A, Williams S, Kumar S, Kheyfets V, Hatton-Jones K
Am J Respir Crit Care Med. 2024; 210(3):329-342.
PMID: 38568479
PMC: 11348978.
DOI: 10.1164/rccm.202307-1310OC.
Ahmad A, Zhang P, Li L, Wang X, Mohsen A, Wang Y
Front Cardiovasc Med. 2023; 10:1249889.
PMID: 37786511
PMC: 10541958.
DOI: 10.3389/fcvm.2023.1249889.
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Bassareo P, DAlto M
Int J Mol Sci. 2023; 24(17).
PMID: 37686034
PMC: 10487467.
DOI: 10.3390/ijms241713227.
Updated perspective of EPAS1 and the role in pulmonary hypertension.
Wang N, Hua J, Fu Y, An J, Chen X, Wang C
Front Cell Dev Biol. 2023; 11:1125723.
PMID: 36923253
PMC: 10008962.
DOI: 10.3389/fcell.2023.1125723.
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
Gu S, Goel K, Forbes L, Kheyfets V, Yu Y, Tuder R
Compr Physiol. 2023; 13(1):4295-4319.
PMID: 36715285
PMC: 10392122.
DOI: 10.1002/cphy.c220010.
Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker.
Winkler T, Kohli P, Kelly V, Kehl E, Witkin A, Rodriguez-Lopez J
Respir Res. 2022; 23(1):325.
PMID: 36457013
PMC: 9714016.
DOI: 10.1186/s12931-022-02239-8.
Salt-inducible kinase 1 deficiency promotes vascular remodeling in pulmonary arterial hypertension via enhancement of yes-associated protein-mediated proliferation.
Pu J, Wang F, Ye P, Jiang X, Zhou W, Gu Y
Heliyon. 2022; 8(10):e11016.
PMID: 36276742
PMC: 9582722.
DOI: 10.1016/j.heliyon.2022.e11016.
HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape.
Medrano-Garcia S, Morales-Cano D, Barreira B, Vera-Zambrano A, Kumar R, Kosanovic D
Cells. 2022; 11(15).
PMID: 35954255
PMC: 9368261.
DOI: 10.3390/cells11152414.
Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.
Lee M, Sanders L, Kumar R, Hernandez-Saavedra D, Yun X, Ford J
Am J Physiol Lung Cell Mol Physiol. 2022; 323(3):L355-L371.
PMID: 35763400
PMC: 9448289.
DOI: 10.1152/ajplung.00039.2022.
Increasing angiotensin-converting enzyme (ACE) 2/ACE axes ratio alleviates early pulmonary vascular remodeling in a porcine model of acute pulmonary embolism with cardiac arrest.
Xiao H, Zhao L, Yang J, Tong N, An L, Wang G
World J Emerg Med. 2022; 13(3):208-214.
PMID: 35646211
PMC: 9108909.
DOI: 10.5847/wjem.j.1920-8642.2022.052.
Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?.
Li K, Wang Z, Ongachwa Machuki J, Li M, Wu Y, Niu M
Front Physiol. 2022; 13:848867.
PMID: 35530510
PMC: 9075737.
DOI: 10.3389/fphys.2022.848867.
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
Upton P, Dunmore B, Li W, Morrell N
Dev Dyn. 2022; 252(3):327-342.
PMID: 35434863
PMC: 10952790.
DOI: 10.1002/dvdy.478.
Evidence supporting a role for circulating macrophages in the regression of vascular remodeling following sub-chronic exposure to hemoglobin plus hypoxia.
Karoor V, Swindle D, Pak D, Strassheim D, Fini M, Dempsey E
Pulm Circ. 2021; 11(4):20458940211056806.
PMID: 34777787
PMC: 8573496.
DOI: 10.1177/20458940211056806.
Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.
Buehler P, Swindle D, Pak D, Fini M, Hassell K, Nuss R
Pulm Circ. 2021; 11(4):20458940211055996.
PMID: 34777785
PMC: 8579334.
DOI: 10.1177/20458940211055996.
Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.
Buehler P, Swindle D, Pak D, Ferguson S, Majka S, Karoor V
Free Radic Biol Med. 2021; 175:95-107.
PMID: 34478834
PMC: 9231663.
DOI: 10.1016/j.freeradbiomed.2021.08.238.
Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis.
Liu C, Sun H, Tang M, Li J, Zhang X, Cao G
Ann Thorac Cardiovasc Surg. 2021; 27(6):380-388.
PMID: 34011805
PMC: 8684839.
DOI: 10.5761/atcs.oa.21-00027.
Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases.
Huang A, Kandhi S, Sun D
Adv Exp Med Biol. 2021; 1303:107-127.
PMID: 33788190
DOI: 10.1007/978-3-030-63046-1_7.